261 related articles for article (PubMed ID: 34818071)
21. Human immunodeficiency virus type 1 infection of neonatal severe combined immunodeficient mice xenografted with human cord blood cells.
Reinhardt B; Torbett BE; Gulizia RJ; Reinhardt PP; Spector SA; Mosier DE
AIDS Res Hum Retroviruses; 1994 Feb; 10(2):131-41. PubMed ID: 8198867
[TBL] [Abstract][Full Text] [Related]
22. Human regulatory T cells control xenogeneic graft-versus-host disease induced by autologous T cells in RAG2-/-gammac-/- immunodeficient mice.
Mutis T; van Rijn RS; Simonetti ER; Aarts-Riemens T; Emmelot ME; van Bloois L; Martens A; Verdonck LF; Ebeling SB
Clin Cancer Res; 2006 Sep; 12(18):5520-5. PubMed ID: 17000688
[TBL] [Abstract][Full Text] [Related]
23. HIV Replication and Latency in a Humanized NSG Mouse Model during Suppressive Oral Combinational Antiretroviral Therapy.
Satheesan S; Li H; Burnett JC; Takahashi M; Li S; Wu SX; Synold TW; Rossi JJ; Zhou J
J Virol; 2018 Apr; 92(7):. PubMed ID: 29343582
[TBL] [Abstract][Full Text] [Related]
24. Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex.
King MA; Covassin L; Brehm MA; Racki W; Pearson T; Leif J; Laning J; Fodor W; Foreman O; Burzenski L; Chase TH; Gott B; Rossini AA; Bortell R; Shultz LD; Greiner DL
Clin Exp Immunol; 2009 Jul; 157(1):104-18. PubMed ID: 19659776
[TBL] [Abstract][Full Text] [Related]
25. A new xenograft model for graft-versus-host disease by intravenous transfer of human peripheral blood mononuclear cells in RAG2-/- gammac-/- double-mutant mice.
van Rijn RS; Simonetti ER; Hagenbeek A; Hogenes MC; de Weger RA; Canninga-van Dijk MR; Weijer K; Spits H; Storm G; van Bloois L; Rijkers G; Martens AC; Ebeling SB
Blood; 2003 Oct; 102(7):2522-31. PubMed ID: 12791667
[TBL] [Abstract][Full Text] [Related]
26. Tocilizumab increases regulatory T cells, reduces natural killer cells and delays graft-versus-host disease development in humanized mice treated with post-transplant cyclophosphamide.
Sligar C; Cuthbertson P; Miles NA; Adhikary SR; Elhage A; Zhang G; Alexander SI; Sluyter R; Watson D
Immunol Cell Biol; 2023 Aug; 101(7):639-656. PubMed ID: 37191045
[TBL] [Abstract][Full Text] [Related]
27. Primary human immunodeficiency virus type 1 viremia and central nervous system invasion in a novel hu-PBL-immunodeficient mouse strain.
Koyanagi Y; Tanaka Y; Kira J; Ito M; Hioki K; Misawa N; Kawano Y; Yamasaki K; Tanaka R; Suzuki Y; Ueyama Y; Terada E; Tanaka T; Miyasaka M; Kobayashi T; Kumazawa Y; Yamamoto N
J Virol; 1997 Mar; 71(3):2417-24. PubMed ID: 9032379
[TBL] [Abstract][Full Text] [Related]
28. CD8-positive lymphocytes in graft-versus-host disease of humanized NOD.Cg-Prkdc(scid)Il2rg(tm1Wjl)/SzJ mice.
Laing ST; Griffey SM; Moreno ME; Stoddart CA
J Comp Pathol; 2015; 152(2-3):238-42. PubMed ID: 25670669
[TBL] [Abstract][Full Text] [Related]
29. T-cell dysfunctions in hu-PBL-SCID mice infected with human immunodeficiency virus (HIV) shortly after reconstitution: in vivo effects of HIV on highly activated human immune cells.
Rizza P; Santini SM; Logozzi MA; Lapenta C; Sestili P; Gherardi G; Lande R; Spada M; Parlato S; Belardelli F; Fais S
J Virol; 1996 Nov; 70(11):7958-64. PubMed ID: 8892919
[TBL] [Abstract][Full Text] [Related]
30. Inducing Long-Term HIV-1 Latency in the TKO-BLT Mouse Model.
Di Y; Lavender KJ
Methods Mol Biol; 2022; 2407():253-273. PubMed ID: 34985670
[TBL] [Abstract][Full Text] [Related]
31. Human peripheral blood CD4 T cell-engrafted non-obese diabetic-scid IL2rγ(null) H2-Ab1 (tm1Gru) Tg (human leucocyte antigen D-related 4) mice: a mouse model of human allogeneic graft-versus-host disease.
Covassin L; Laning J; Abdi R; Langevin DL; Phillips NE; Shultz LD; Brehm MA
Clin Exp Immunol; 2011 Nov; 166(2):269-80. PubMed ID: 21985373
[TBL] [Abstract][Full Text] [Related]
32. Xenogeneic Graft-Versus-Host Disease in Humanized NSG and NSG-HLA-A2/HHD Mice.
Ehx G; Somja J; Warnatz HJ; Ritacco C; Hannon M; Delens L; Fransolet G; Delvenne P; Muller J; Beguin Y; Lehrach H; Belle L; Humblet-Baron S; Baron F
Front Immunol; 2018; 9():1943. PubMed ID: 30214443
[TBL] [Abstract][Full Text] [Related]
33. The human HIV/peripheral blood lymphocyte (PBL)-SCID mouse. A modified human PBL-SCID model for the study of HIV pathogenesis and therapy.
Boyle MJ; Connors M; Flanigan ME; Geiger SP; Ford H; Baseler M; Adelsberger J; Davey RT; Lane HC
J Immunol; 1995 Jun; 154(12):6612-23. PubMed ID: 7759895
[TBL] [Abstract][Full Text] [Related]
34. The Establishment of an In Vivo HIV-1 Infection Model in Humanized B-NSG Mice.
Fan TJ; Sun L; Yang XG; Jin X; Sun WW; Wang JH
Virol Sin; 2020 Aug; 35(4):417-425. PubMed ID: 31863357
[TBL] [Abstract][Full Text] [Related]
35. Insights into mechanisms of graft-versus-host disease through humanised mouse models.
Elhage A; Sligar C; Cuthbertson P; Watson D; Sluyter R
Biosci Rep; 2022 Sep; 42(9):. PubMed ID: 35993192
[TBL] [Abstract][Full Text] [Related]
36. Mucosal transmission of R5 and X4 tropic HIV-1 via vaginal and rectal routes in humanized Rag2-/- gammac -/- (RAG-hu) mice.
Berges BK; Akkina SR; Folkvord JM; Connick E; Akkina R
Virology; 2008 Apr; 373(2):342-51. PubMed ID: 18207484
[TBL] [Abstract][Full Text] [Related]
37. Role of Natural Killer Cells in Intravenous Immunoglobulin-Induced Graft-versus-Host Disease Inhibition in NOD/LtSz-scidIL2rg(-/-) (NSG) Mice.
Gregoire-Gauthier J; Fontaine F; Benchimol L; Nicoletti S; Selleri S; Dieng MM; Haddad E
Biol Blood Marrow Transplant; 2015 May; 21(5):821-8. PubMed ID: 25596424
[TBL] [Abstract][Full Text] [Related]
38. A novel humanized mouse model for HIV and tuberculosis co-infection studies.
Bohórquez JA; Adduri S; Ansari D; John S; Florence J; Adejare O; Singh G; Konduru NV; Jagannath C; Yi G
Front Immunol; 2024; 15():1395018. PubMed ID: 38799434
[TBL] [Abstract][Full Text] [Related]
39. PRO 140 Monoclonal Antibody to CCR5 Prevents Acute Xenogeneic Graft-versus-Host Disease in NOD-scid IL-2Ry
Burger DR; Parker Y; Guinta K; Lindner D
Biol Blood Marrow Transplant; 2018 Feb; 24(2):260-266. PubMed ID: 29128556
[TBL] [Abstract][Full Text] [Related]
40. Immunization of BLT Humanized Mice Redirects T Cell Responses to Gag and Reduces Acute HIV-1 Viremia.
Claiborne DT; Dudek TE; Maldini CR; Power KA; Ghebremichael M; Seung E; Mellors EF; Vrbanac VD; Krupp K; Bisesi A; Tager AM; Knipe DM; Boutwell CL; Allen TM
J Virol; 2019 Oct; 93(20):. PubMed ID: 31375576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
